Goldman Sachs Group Inc Aldeyra Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 91,717 shares of ALDX stock, worth $354,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91,717
Previous 147,480 37.81%
Holding current value
$354,027
Previous $517,000 42.17%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$2.77 - $4.22 $154,463 - $235,319
-55,763 Reduced 37.81%
91,717 $299,000
Q4 2023

Feb 13, 2024
SELL
$1.47 - $6.06 $31,168 - $128,490
-21,203 Reduced 12.57%
147,480 $517,000
Q3 2023

May 14, 2024
BUY
$6.11 - $8.16 $129,550 - $173,016
21,203 Added 14.38%
168,683 $1.13 Million
Q3 2023

Nov 14, 2023
SELL
$6.11 - $8.16 $175,680 - $234,624
-28,753 Reduced 14.56%
168,683 $1.13 Million
Q2 2023

May 14, 2024
SELL
$7.11 - $11.89 $638,527 - $1.07 Million
-89,807 Reduced 31.27%
197,436 $1.66 Million
Q2 2023

Aug 14, 2023
SELL
$7.11 - $11.89 $638,527 - $1.07 Million
-89,807 Reduced 31.27%
197,436 $1.66 Million
Q1 2023

May 14, 2024
BUY
$5.77 - $9.93 $1.52 Million - $2.62 Million
263,493 Added 1109.44%
287,243 $2.85 Million
Q1 2023

May 11, 2023
BUY
$5.77 - $9.93 $1.52 Million - $2.62 Million
263,493 Added 1109.44%
287,243 $2.85 Million
Q4 2022

May 14, 2024
SELL
$5.08 - $7.09 $835,949 - $1.17 Million
-164,557 Reduced 87.39%
23,750 $165,000
Q4 2022

Feb 13, 2023
SELL
$5.08 - $7.09 $835,949 - $1.17 Million
-164,557 Reduced 87.39%
23,750 $165,000
Q3 2022

May 14, 2024
SELL
$3.8 - $7.74 $3.79 Million - $7.71 Million
-996,277 Reduced 84.1%
188,307 $1.01 Million
Q3 2022

Nov 10, 2022
SELL
$3.8 - $7.74 $3.79 Million - $7.71 Million
-996,277 Reduced 84.1%
188,307 $1.01 Million
Q2 2022

May 14, 2024
BUY
$2.43 - $4.85 $2.52 Million - $5.03 Million
1,037,104 Added 703.22%
1,184,584 $4.73 Million
Q2 2022

Aug 15, 2022
SELL
$2.43 - $4.85 $501,634 - $1 Million
-206,434 Reduced 14.84%
1,184,584 $4.73 Million
Q1 2022

May 16, 2022
BUY
$3.25 - $5.17 $4.19 Million - $6.66 Million
1,288,353 Added 1254.91%
1,391,018 $6.18 Million
Q4 2021

Feb 14, 2022
SELL
$3.5 - $9.63 $67,865 - $186,725
-19,390 Reduced 15.89%
102,665 $410,000
Q3 2021

Nov 10, 2021
BUY
$7.94 - $11.31 $969,116 - $1.38 Million
122,055 New
122,055 $1.07 Million

Others Institutions Holding ALDX

# of Institutions
106
Shares Held
35.4M
Call Options Held
104K
Put Options Held
88.1K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $225M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email